NUZ 5.26% 20.0¢ neurizon therapeutics limited

PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-967

  1. 8,977 Posts.
    lightbulb Created with Sketch. 1763
    yes I maybe the resident wringer on here, but just look at the history of PAA.
    Human cancer phase 1 results good but had adverse affects but remembering that human cancer was the reason PAA was set up, but now it's canned.
    So then it was canine cancer phase 1, phase 2a and phase 2b, this had a two prong attack one to prove new tablets were ok to use and the other to help with human cancer, so where is canine cancer oh yes canned.
    So then we moved to covid with only clinical data but again this data was also to help with human cancer trials, but where is the covid testing again oh yes canned and never mentioned.
    So now we have great mnd data or so we are told around the phase 1 so how do you know that MND will not end up the same as Human, canine cancer and covid.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $98.34M
Open High Low Value Volume
20.0¢ 20.5¢ 19.5¢ $86.20K 429.7K

Buyers (Bids)

No. Vol. Price($)
3 67508 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 36444 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.